Prosecution Insights
Last updated: November 12, 2026
Application No. 18/690,844

WHOLE-MUSCLE MEAT ANALOGUES WITH FLUID ACCOMMODATING SPACES AND METHOD OF PRODUCING THE SAME

Non-Final OA §103§112
Filed
Mar 11, 2024
Priority
Sep 13, 2021 — IL 286331 +1 more
Examiner
TRAN, LIEN THUY
Art Unit
1793
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Redefine Meat Ltd.
OA Round
1 (Non-Final)
29%
Grant Probability
At Risk
1-2
OA Rounds
55%
With Interview

Examiner Intelligence

Grants only 29% of cases
29%
Career Allowance Rate
261 granted / 908 resolved
-36.3% vs TC avg
Strong +26% interview lift
Without
With
+26.5%
Interview Lift
resolved cases with interview
Typical timeline
Avg Prosecution
72 currently pending
Career history
1000
Total Applications
across all art units

Office Action

§103 §112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Group I, claims 31-39 and 50 in the reply filed on 8/24/26 is acknowledged. Claims 40-49 are withdrawn from consideration as being directed to non-elected invention. Priority Receipt is acknowledged of certified copies of papers required by 37 CFR 1.55. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 31 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. In claim 31, the recitation of “ the longitudinal direction” does not have proper antecedent basis. Line 13, the limitation “ said fluid” is vague and indefinite because it’s unclear what fluid the claim is referring to. Previous lines recite fluid accommodating spaces; there is no recitation of any fluid. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim(s) 31-37,39 is/are rejected under 35 U.S.C. 103 as being unpatentable over Scionti ( WO 2020030628) For claim 31, Scionti discloses a meat analog product having texture and mechanical properties resembling traditional meat with high skeletal fibrous consistency. The product comprises protein mass in form of sheet comprising protein filaments. The layers are made of microextruded protein filaments. The filaments at several densities per unit surface. When a percentage of microextruded filaments per unit of layer surface is under 100%, it means that the filaments are disposed in parallel but they are not in contact thus leading empty spaces between filaments. The empty spaces between filaments are the same as the claimed plurality of fluid accommodating spaces. The spaces are parallel to the protein strands. Thus they are elongated and has first end and second end. The spaces are empty which means it's airy gas spaces. The filaments are in form of threads with a longitudinal section higher than its cross section layers. They have a cross section with a diameter from 10 microns to 1000 microns. The filaments are arranged in parallel; thus, all the filaments are in parallel encompassing the claimed at least 60%. For claim 32, since the protein filaments are arranged in parallel. It’s obvious the ends are exposed externally. For claim 33, as shown in figure 11, the spaces do have a definite shape. So they are amorphouse in shape. For claim 35, Scionti discloses the protein filaments are arranged not touching so that there are spaces, there is no disclosure of having different length of filaments. Thus, it obviously inherent they are off the same length and cross sectional dimensions. For claim 37, figure 13 shows a slab defining a horizontal plane and cross sectional dimension being perpendicular to the horizontal plane. When the filaments are arranged in parallel to form the slab, the empty spaces are perpendicular to the horizontal plane. For claim 39, Scionti discloses the protein mass comprises texture protein. ( see pages 4-5, 19,29) Scionti does not specifically disclose at least 2mm and twice larger than the cross sectional dimension as in claim 31, the dimension as in claim 34 and the volume as in claim 36. It would have been obvious to one of ordinary skill in the art to form the filaments any length depending on the shape desired. The empty elongated spaces would be the same length as the filaments. It would have been obvious to arrange the filaments in any varying arrangement to have any varying dimension between empty spaces as an obvious matter of shape and size desired. Such parameter can readily be determined by one skilled in the art. It would have been obvious to vary the volume contributed by the empty spaces depending on the density of the filament desired to make the layers. Scionti discloses the percentage can be up to 100%. Claim(s) 38,50 is/are rejected under 35 U.S.C. 103 as being unpatentable over Scionti (WO 2020/030628) in view of Geistlinger ( 2017/0035076). Scionti does not disclose method marinating as in claim 50. Geistlinger discloses products having structures, textures and other similar properties to those of animal meat. The protein fibrous products can be marinated by immersing in a marinade. ( see paragraphs 0123,0125) The marination in claim 38 is an intended use which does not determine the patentability of the product. In any event, marinading meat product is well known and marinading meat analog product is known as shown in Geistlinger. It would have been obvious to one of ordinary skill in the art to marinade the Scionti product when desiring to obtain enhanced flavoring. The marinade will absorb into the product and the empty spaces. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to LIEN THUY TRAN whose telephone number is (571)272-1408. The examiner can normally be reached Monday-Thursday. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Emily Le can be reached at 571-272-0903. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. September 16, 2026 /LIEN T TRAN/Primary Examiner, Art Unit 1793
Read full office action

Prosecution Timeline

Mar 11, 2024
Application Filed
Sep 17, 2026
Non-Final Rejection mailed — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12778171
BAKE-STABLE FILLING COMPOSITION
3y 3m to grant Granted Nov 03, 2026
Patent 12745788
METHOD FOR PREPARING LEGUMES POWDER USING AQUAFABA
2y 6m to grant Granted Sep 29, 2026
Patent 12690601
PLANT-BASED DELI MEAT ANALOGUE PRODUCTS COMPRISING TITANIUM DIOXIDE
1y 8m to grant Granted Jul 28, 2026
Patent 12648576
METHOD FOR PREPARING LINSEED MERINGUE FROM LINSEED
2y 10m to grant Granted Jun 09, 2026
Patent 12622437
Dual Textured Food
4y 1m to grant Granted May 12, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
29%
Grant Probability
55%
With Interview (+26.5%)
Low
PTA Risk
Based on 908 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month